ElevateBio CEO on disruptive potential for gene and cell therapies
0
0
14/05/24
David Hallal, ElevateBio CEO, joins 'Fast Money' to talk making CNBC's Disruptor 50 list, what is included in its portfolio, innovation in cell and gene therapy and more.
Prikaži više
0 Komentari
sort Poredaj po
